These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38494667)

  • 61. Increase in CD4 cell counts between 2 and 3.5 years after initiation of antiretroviral therapy and determinants of CD4 progression in India.
    Rajasekaran S; Jeyaseelan L; Raja K; Vijila S; Krithigaipriya KA; Kuralmozhi R
    J Postgrad Med; 2009; 55(4):261-6. PubMed ID: 20083872
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
    Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
    Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Baseline Characteristics of Mitochondrial DNA and Mutations Associated With Short-Term Posttreatment CD4+T-Cell Recovery in Chinese People With HIV.
    Liu A; Wei Q; Lin H; Ding Y; Sun YV; Zhao D; He J; Ma Z; Li F; Zhou S; Chen X; Shen W; Gao M; He N
    Front Immunol; 2021; 12():793375. PubMed ID: 34970271
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.
    Rajasuriar R; Gouillou M; Spelman T; Read T; Hoy J; Law M; Cameron PU; Petoumenos K; Lewin SR
    PLoS One; 2011; 6(6):e20713. PubMed ID: 21674057
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.
    Silveira MP; Maurer P; Guttier MC; Moreira LB
    J Clin Pharm Ther; 2015 Apr; 40(2):192-5. PubMed ID: 25422132
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.
    Phillips AN; Staszewski S; Weber R; Kirk O; Francioli P; Miller V; Vernazza P; Lundgren JD; Ledergerber B; ; ;
    JAMA; 2001 Nov; 286(20):2560-7. PubMed ID: 11722270
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High baseline body mass index predicts recovery of CD4+ T lymphocytes for HIV/AIDS patients receiving long-term antiviral therapy.
    Zhu J; Huang H; Wang M; Zhang Y; Mo J; Tian W; Tan S; Jiang L; Meng Z; Qin S; Ning C
    PLoS One; 2022; 17(12):e0279731. PubMed ID: 36584083
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART.
    Gerna G; Piccinini G; Genini E; Percivalle E; Zavattoni M; Lilleri D; Testa L; Comolli G; Maserati R; Baldanti F; Maccario R; Monforte AD; Revello MG
    J Acquir Immune Defic Syndr; 2001 Dec; 28(4):320-31. PubMed ID: 11707667
    [TBL] [Abstract][Full Text] [Related]  

  • 69. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
    Ledergerber B; Egger M; Erard V; Weber R; Hirschel B; Furrer H; Battegay M; Vernazza P; Bernasconi E; Opravil M; Kaufmann D; Sudre P; Francioli P; Telenti A
    JAMA; 1999 Dec; 282(23):2220-6. PubMed ID: 10605973
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression.
    Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA
    AIDS Res Hum Retroviruses; 2009 Jun; 25(6):756-76. PubMed ID: 19500017
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Study on the mortality and risk factors among HIV/AIDS patients receiving antiretroviral therapy in Xinjiang Uygur Autonomous Region].
    Ni M; Chen X; Hu X; Ma Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Nov; 48(11):953-8. PubMed ID: 25582364
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence.
    Yanik EL; Napravnik S; Cole SR; Achenbach CJ; Gopal S; Dittmer DP; Olshan AF; Kitahata MM; Mugavero MJ; Saag M; Moore RD; Mathews WC; Hunt P; Eron JJ
    AIDS; 2014 Apr; 28(7):979-87. PubMed ID: 24681415
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antiretroviral therapy for HIV-2 infected patients.
    Smith NA; Shaw T; Berry N; Vella C; Okorafor L; Taylor D; Ainsworth J; Choudhury A; Daniels RS; El-Gadi S; Fakoya A; Moyle G; Oxford J; Tedder R; O'Shea S; de Ruiter A; Breuer J
    J Infect; 2001 Feb; 42(2):126-33. PubMed ID: 11531319
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384.
    Grady BJ; Samuels DC; Robbins GK; Selph D; Canter JA; Pollard RB; Haas DW; Shafer R; Kalams SA; Murdock DG; Ritchie MD; Hulgan T;
    J Acquir Immune Defic Syndr; 2011 Dec; 58(4):363-70. PubMed ID: 21792066
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunovirological discordance among female sex workers who start antiretroviral therapy in Burkina Faso.
    Bazié WW; Somé DY; Traoré IT; Sanon A; Konaté I; Tassembedo S; Taofiki AO; Kania D; Ouédraogo A; Vuylsteke B; Gilbert C; Meda N; Ouédraogo AS; Nagot N
    BMC Infect Dis; 2022 Feb; 22(1):117. PubMed ID: 35114959
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A retrospective clinical study of dolutegravir- versus efavirenz-based regimen in treatment-naïve patients with advanced HIV infection in Nanjing, China.
    Zhong M; Li M; Qi M; Su Y; Yu N; Lv R; Ye Z; Zhang X; Xu X; Cheng C; Chen C; Wei H
    Front Immunol; 2022; 13():1033098. PubMed ID: 36700216
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study.
    Huang Y; Zhou O; Zheng Z; Xu Y; Shao Y; Qin C; Qin F; Lai J; Liu H; Chen R; Ye L; Liang H; Qin X; Jiang J
    AIDS Res Ther; 2020 Jul; 17(1):44. PubMed ID: 32680536
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.
    Baker JV; Peng G; Rapkin J; Abrams DI; Silverberg MJ; MacArthur RD; Cavert WP; Henry WK; Neaton JD;
    AIDS; 2008 Apr; 22(7):841-8. PubMed ID: 18427202
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antiretroviral therapy programme outcomes at Senkatana antiretroviral therapy clinic, Lesotho: a four-year retrospective cohort study.
    Kabuya M; Musekiwa A; Takuva S; Thabane L; Mbuagbaw L
    Pan Afr Med J; 2023; 46():74. PubMed ID: 38282767
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Opportunistic infections among people living with HIV/AIDS attending antiretroviral therapy clinics in Gedeo Zone, Southern Ethiopia.
    Gebremichael G; Tadele N; Gebremedhin KB; Mengistu D
    BMC Res Notes; 2024 Aug; 17(1):225. PubMed ID: 39148100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.